ID: MRFR/LS/0620-HCR | August 2022 | Region: Global | 200 Pages
Table of Contents
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Threats
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & supply: gap analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger and Acquisition Landscape
5.7 Up-Coming trends in Blood Transfusion Diagnostics market
5.7.1 Market trends
5.7.2 Technological trends
6. Global Blood Transfusion Diagnostics market by product
6.1 Red Blood Cells
6.2 Platelets
6.3 Plasma
6.4 Albumin
6.5 Immunoglobulin Preparations
7. Global Blood Transfusion Diagnostics market by technology
7.1 Western Blot
7.2 ELISA
7.2.1 Chemiluminescence immunoassay
7.2.2 Fluorescence immunoassays
7.3.3 Colorimetric immunoassay
7.3 Nucleic Acid Amplification
7.3.1 Thermomechanical analysis (TMA)
7.3.2 Real-time PCR
7.4 Fluorescence assay
7.5 Rapid Test
8. Global Blood Transfusion Diagnostics market by end user
8.1 Hospitals
8.2 Clinics
8.3 Blood banks
8.4 Laboratories
9. Global Blood Transfusion Diagnostics market by region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 UK
9.3.1.3 France
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Republic of Korea
9.4.5 Australia
9.4.6 Rest of Asia-Pacific
9.5 Middle East and Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Qatar
9.5.5 Kuwait
9.5.6 Rest of Middle East and Africa
10 Competitive Landscape
11 Company Profile
11.1 Grifols
11.1.1 Overview
11.1.2 Product/Business Segment Overview
11.1.3 Financial Updates
11.1.4 Key Developments
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Overview
11.2.2 Product/Business Segment Overview
11.2.3 Financial Updates
11.2.4 Key Developments
11.3 Roche Diagnostics
11.3.1 Overview
11.3.2 Product/Business Segment Overview
11.3.3 Financial Updates
11.3.4 Key Developments
11.4 Biomérieux
11.4.1 Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Updates
11.4.4 Key Development
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Overview
11.5.2 Product/Business Segment Overview
11.5.3 Financial Updates
11.5.4 Key Developments
11.6 Immucor
11.6.1 Overview
11.6.2 Product/Business Segment Overview
11.6.3 Financial Updates
11.6.4 Key Developments
11.7 Siemens Healthineers
11.7.1 Overview
11.7.2 Product/Business Segment Overview
11.7.3 Financial Updates
11.7.4 Key Developments
11.8 Becton, Dickinson and Company
11.8.1 Overview
11.8.2 Product/Business Segment Overview
11.8.3 Financial Updates
11.8.4 Key Developments
11.9 Others
12 Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Blood Transfusion Diagnostics Industry
13 Appendix
 
LIST OF TABLES
Table 1 Blood Transfusion Diagnostics Industry Synopsis, 2020-2027
Table 2 Global Blood Transfusion Diagnostics Market Estimates & Forecast, 2020-2027, (USD Million)
Table 3 Global Blood Transfusion Diagnostics Market, by Region, 2020-2027, (USD Million)
Table 4 Global Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)
Table 5 Global Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)
Table 6 Global Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 7 Americas Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)
Table 8 Americas Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)
Table 9 Americas Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 10 North America Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)
Table 11 North America Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)
Table 12 North America Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 13 South America Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)
Table 14 South America Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)
Table 15 South America Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 16 Europe Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)
Table 17 Europe Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)
Table 18 Europe Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 19 Western Europe Blood Transfusion Diagnostics Market by Product, 2020-2027, (USD Million)
Table 20 Western Europe Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)
Table 21 Western Europe Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 22 Eastern Europe Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)
Table 23 Eastern Europe Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)
Table 24 Eastern Europe Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 25 Asia Pacific Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)
Table 26 Asia Pacific Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)
Table 27 Asia Pacific Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million)
Table 28 Middle East & Africa Blood Transfusion Diagnostics Market, by Product, 2020-2027, (USD Million)
Table 29 Middle East & Africa Blood Transfusion Diagnostics Market, by Technology, 2020-2027, (USD Million)
Table 30 Middle East & Africa Blood Transfusion Diagnostics Market, by End-User, 2020-2027, (USD Million) 
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Blood Transfusion Diagnostics Market
Figure 3 Segmentation Market Dynamics for Blood Transfusion Diagnostics Market
Figure 4 Global Blood Transfusion Diagnostics Market Share, by Product 2020
Figure 5 Global Blood Transfusion Diagnostics Market Share, by Technology 2020
Figure 6 Global Blood Transfusion Diagnostics Market Share, by End Users, 2020
Figure 7 Global Blood Transfusion Diagnostics Market Share, by Region, 2020
Figure 8 Americas Blood Transfusion Diagnostics Market Share, by Country, 2020
Figure 9 Europe Blood Transfusion Diagnostics Market Share, by Country, 2020
Figure 10 Asia Pacific Blood Transfusion Diagnostics Market Share, by Country, 2020
Figure 11 Middle East & Africa Blood Transfusion Diagnostics Market Share, by Country, 2020
Figure 12 Global Blood Transfusion Diagnostics Market: Company Share Analysis, 2020 (%)
$2.45 Million
8.2%
North America
2021-2028
Blood Transfusion Diagnostics Market Overview
Blood Transfusion Diagnostics Market Size is expected to reach USD 2.45 billion in 2023 from USD 1.50 billion in 2016 with a CAGR of approximately 8.2% during the forecast period. Blood transfusion diagnostics is the intravenous transfer of blood or blood products. Blood transfusions can be used to replace blood components that have been lost. The most common blood components transfused include red blood cells, white blood cells, platelets, clotting factors, and plasma. During an emergency or a serious case of massive blood loss, these blood components are crucial to laboratories and hospitals. When hemoglobin levels fall below 100g/L, RBC transfusion is required. Before being transfused, blood from a donor must be checked for a variety of infectious diseases. Blood transfusion demand is being driven by the rising prevalence of chronic and infectious diseases such as severe anemia, cancer, hemophilia, kidney disease, liver disease, severe infection, sickle cell disease, and thrombocytopenia, as well as the introduction of technologically advanced products.
As a result, blood transfusion diagnostics play a vital role in preventing infection in both the recipient and the healthcare workers. The expansion of this market is fueled by rising infectious disease prevalence, an increase in the number of blood transfusion procedures, the need for screened blood products, and increased campaigning or awareness campaigns. The demand for blood and blood products outnumbers the supply, adding to the Blood Transfusion Diagnostics market's expansion.
Study objectives: Main objective of this research is to provide information about Blood Transfusion Diagnostics market, product, technology and end users.
Intended Audience
Figure 1: Blood Transfusion Diagnostics market, by technology, 2016:
Source: Press Release, Company presentation, annual reports
Segmentation:
Blood Transfusion Diagnostics market has been segmented on the basis of blood product including Red Blood Cells, Platelets, Plasma, Albumin, Immunoglobulin Preparations and other products. On the basis of technology, the market is segmented into Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test and other technologies. ELISA is further segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassays (FIA), and colorimetric immunoassay (CI). Nucleic Acid Amplification is segmented into Thermomechanical analysis (TMA) and real-time PCR. End users are hospitals, clinics, blood banks, laboratories.
Regional Analysis:
Globally, Blood Transfusion Diagnostics market consists of four regions Americas, Europe, Asia Pacific and Middle East and Africa. America is the largest market whose growth is attributed to an increase in the use of nucleic acid amplification test and large number of awareness programs conducted by the government bodies and non-government organizations. Europe is the second largest market. Asia Pacific is showing positive growth this market. The market shows steady growth in Middle East & Africa.
Figure 2: Market Synopsis
Sources: Press Release, presentation, company website, annual reports, government records, journals expert interview.
Key Players
Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), Roche Diagnostics (Switzerland), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Immucor (U.S), Siemens Healthineers (Germany), Ortho Clinical Diagnostics, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Ortho Clinical Diagnostics (U.S), Beckman Coulter (U.S), Diagast (France), Abbott Diagnostics (U.S), BAG healthcare (Germany), DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S), Biokit (Spain).
The report for Blood Transfusion Diagnostics market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
Frequently Asked Questions (FAQ) :
Global Blood Transfusion Diagnostics Market is expected to be valued at USD 2.45 billion in 2023, rising from USD 1.5 billion in 2016.
Blood Transfusion Diagnostics Market is expected to exhibit a strong 8.2% CAGR over the forecast period from 2017 to 2023.
Increasing volume of blood transfusions is likely to be a key driver for the Blood Transfusion Diagnostics Market.
Americas are the largest Blood Transfusion Diagnostics Market.
Leading players in the Blood Transfusion Diagnostics Market include Roche Diagnostics, Thermo Fisher, and Grifols, among others.